A map of Europe showing country borders and the surrounding Atlantic Ocean, with a radar grid overlay in black and green.

Serving patients across Europe

Pan European reach

Access to treatment should not depend on location

Founded in 2022 and based in Amsterdam, we partner with biotech innovators to unlock the full commercial value of orphan medicines across the continent.

Our deep expertise in market access allows us to navigate Europe’s complex landscape with precision and purpose, ensuring no patient battling a rare disease is left behind.

Delivering access across Europe

  • Across borders

    Serving patients across Europe

    Rare diseases do not stop at borders.
    We work across multiple European markets, partnering with local healthcare systems to support responsible supply and ongoing access to treatment.

  • In-country expertise

    Local market understanding

    Each country has its own healthcare system and regulatory landscape.
    We work with trusted in-country partners to ensure access reflects national requirements and local patient needs.

  • Connected delivery

    Coordinated European approach

    Alongside local expertise, we take a joined-up European view.
    This allows us to maintain high standards, consistency, and compliance across all markets we serve.

  • Patient at the centre

    Patient-first, always

    Patients sit at the centre of every decision we make.
    Our focus is on safety, continuity of supply, and long-term access - because access matters.

Map of Europe highlighting countries including Finland, Sweden, Norway, Denmark, Germany, and France.

Our reach

Avanzanite operates across a growing number of European markets, supporting access through local partnerships.

  • Austria

  • Belgium

  • Bulgaria

  • Croatia

  • Republic of Cyprus

  • Czechia

  • Denmark

  • Estonia

  • Finland

  • France

  • Germany

  • Greece

  • Hungary

  • Ireland

  • Italy

  • Latvia

  • Lithuania

  • Luxembourg

  • Malta

  • Netherlands

  • Poland

  • Portugal

  • Romania

  • Slovakia

  • Slovenia

  • Spain

  • Sweden

  • Iceland

  • Liechtenstein

  • Norway

  • Switzerland

  • United Kingdom

Making access possible

Because where a patient lives should not limit their care.
See how our pan-European approach supports patients across Europe.

Contact US